All Resources for 'Research, Data & Evaluation'
Pharmacotherapy Specialist Role in Rehabilitation Centres
Accelerating Drug Use Prevention Systems in Drug Policy; New Initiatives
Prescribed safer supply during dual public health emergencies: a qualitative study examining service providers perspectives on early implementation
Background: Over the past decade, drug-related overdoses have seen a significant rise both in North America and globally. The COVID-19 pandemic has further emphasised the urgent need for safer supply programs to replace unregulated...
1st International Conference on Drug Research and Policy 2024
Present your work at the 1st International Conference on Drugs Research and Policy 2024!
The global approach to drugs and substance policy is a multifaceted challenge involving numerous nations and organizations. Many United Nations focal...
Tools to implement measurement-based care (MBC) in the treatment of opioid use disorder (OUD): toward a consensus
Abstract
Background
The prevalence and associated overdose death rates from opioid use disorder (OUD) have dramatically increased in the last decade. Despite more available treatments than 20 years ago, treatment access and high...
Tobacco use and behaviour among South African adolescents and young adults: systematic review and meta-analysis
Abstract
Objective Tobacco use, particularly the initiation of smoking during adolescence and young adulthood, represents a significant public health concern in South Africa. This study aims to conduct a comprehensive review of published...
Pharmacy Automation in Rehabilitation Centres
Global Civil Society Report for the 2024 mid-term review of the Commission on Narcotic Drugs
The Vienna & New York NGO Committees on Drugs are pleased to present the global civil society report for the 2024 mid-term review of the Commission on Narcotic Drugs (CND).
The report is the result of constructive inputs by more than 200...
Call for Speakers for the CND High-Level Segment in March 2024
The Commission on Narcotic Drugs (CND) will hold on 14-15 March 2024 a High Level Segment to conduct the 2024 Mid-Term Review. The Review will focus on taking stock of the implementation of all existing international drug policy commitments...